Experience with the Mixed Meal Test in Diagnosing GIP-Dependent Cortisol Hypersecretion at a Tertiary Center
Experimental and Clinical Endocrinology & Diabetes · 01.08.2025 · 133 (08) · 408-414
DOI: 10.1055/a-2676-1138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.08.2025. Verfasst von Tugba Barlas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Metabolism, Gazi University, Ankara, Turkey. Hauptthemen laut MEDLINE: Gastric Inhibitory Polypeptide, Hydrocortisone, Receptors, Gastrointestinal Hormone, Cushing Syndrome. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
Aberrant expression of glucose-dependent insulinotropic peptide receptors (GIPR) might regulate increased steroidogenesis in patients with ACTH-independent cortisol hypersecretion. This study investigated the presence of aberrant GIPR expression in patients with ACTH-independent cortisol hypersecretion and bilateral adrenal adenomas. Patients with bilateral adrenal adenomas, ACTH-independent CS and aberrant GIPR screened via mixed meal test were included. Patients’ demographic features and laboratory and imaging findings were obtained retrospectively. Twenty-one patients were included. Overt CS findings were present in 14.3% of the patients. One patient (4.7%) had a complete positive response (537% increase) and one patient (4.7%) had a partial response (41% increase) to the mixed meal test. In the remaining 19 patients, a mean change of -10.1% (range: −56.5% to+24.7%) in cortisol levels was observed at 120 min compared to baseline. The patient with a complete positive response was confirmed using 100 µg of IV octreotide. The patient underwent unilateral adrenalectomy after an inadequate long-term response to octreotide LAR therapy. The histopathology revealed bilateral macronodular adrenal cortical disease. We identified a germline heterozygous frameshift variant in the KDM1A gene in the patient’s blood sample and a recurrent deletion of the p arm of chromosome 1 harboring the KDM1A locus in the adrenal sample. These results may provide useful insights into the screening of aberrant GIPR expression in patients with ACTH-independent hypercortisolism. It is essential to further investigate which patients require screening. Moreover, a significant cortisol peak observed during the mixed meal test in the presence of these receptors has drawn attention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Endocrinology and Metabolism, Gazi University, Ankara, Turkey.
- Medical Genetics, Gazi University, Ankara, Turkey.
- Urology, Gazi University, Ankara, Turkey.
- Pathology, Gazi University, Ankara, Turkey.
ORCID-Profile: Tugba Barlas, Gulsum Kayhan, Mehmet Muhittin Yalcin, Ethem Turgay Cerit, Mujde Akturk, Fusun Balos Toruner, Sinan Sozen, Aylar Poyraz, Ayhan Karakoç, Alev Eroglu Altinova
Zitieren
APA
Barlas, T., Kayhan, G., Yalcin, M. M., Cerit, E. T., Akturk, M., Toruner, F. B., Sozen, S., Poyraz, A., Karakoç, A., & Altinova, A. E. (2025). Experience with the Mixed Meal Test in Diagnosing GIP-Dependent Cortisol Hypersecretion at a Tertiary Center. Experimental and Clinical Endocrinology & Diabetes, 133(08), 408-414. https://doi.org/10.1055/a-2676-1138
Vancouver
Barlas T, Kayhan G, Yalcin MM, Cerit ET, Akturk M, Toruner FB, et al. Experience with the Mixed Meal Test in Diagnosing GIP-Dependent Cortisol Hypersecretion at a Tertiary Center. Experimental and Clinical Endocrinology & Diabetes. 2025;133(08):408-414. doi:10.1055/a-2676-1138
BibTeX
@article{Barlas2025,
author = {Barlas, Tugba and Kayhan, Gulsum and Yalcin, Mehmet Muhittin and Cerit, Ethem Turgay and Akturk, Mujde and Toruner, Fusun Balos and Sozen, Sinan and Poyraz, Aylar and Karakoç, Ayhan and Altinova, Alev Eroglu},
title = {Experience with the Mixed Meal Test in Diagnosing GIP-Dependent Cortisol Hypersecretion at a Tertiary Center},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2025},
volume = {133},
number = {08},
pages = {408--414},
doi = {10.1055/a-2676-1138}
}
EUVIMED